US 9669004
Daidzein analogs as treatment for cancer
granted A61KA61K31/352A61K31/353
Quick answer
US patent 9669004 (Daidzein analogs as treatment for cancer) held by United States Department of Agriculture expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States Department of Agriculture
- Grant date
- Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/352, A61K31/353, A61P, A61P35/00